Covishield vaccine approved, vaccination from next week; Possibility of final approval of drug control today
Central Committee of Experts recommends emergency use of Covishield vaccine
The way has been cleared for emergency use of the corona vaccine in the country. On Friday, the Centre's committee of experts approved the Oxford-AstraZeneca vaccine Covishield. Final approval is expected on Saturday from the drug controller. Its 50 million doses are ready and will be delivered by air to regional centers across the country in a day or two. The vaccination campaign will start on January 6 and 7.
The CDSCO's expert committee has recommended that Kovishiland be approved, and the DGCI will now consider and finalize the recommendation. If this happens, it will be the first vaccine to be approved for emergency approval in India. The central government has already made preparations for rehearsals for vaccination.
The vaccine will reach us this way
10 million health workers to be vaccinated by February, 20 million frontline workers to be vaccinated by March
The vaccine is currently kept in Himachal
The government will first buy the vaccine from the serum. 50 million doses have been approved by the Central Drugs Laboratory of Himachal. Serum will be responsible for delivering from there to Regional Centers. From there it will reach the capitals. States will then start vaccination according to their strategy.
Prepare a list of 1 crore people
1 crore health workers will be vaccinated first. All the states have sent their lists to the Center. Feb them. Will be vaccinated by Frontline workers like police, municipal employees will then be vaccinated. Their number is around 2 crores. The Center has also sought their list. They will be vaccinated by March.
That's why rehearsals across the country today
The final rehearsal of the vaccination will take place on Saturday. It will review the supply, storage and logistics of vaccines. Rehearsals will take place at 3-3 centers in 2 cities in each state. Health Minister Dr. Harshvardhan reviewed.
Covishield effective up to 70%
Covishield was found to be 90% effective in clinical trials. However, the Human Trial had different results in Britain and India. The central government believes it is up to 70% effective. E-Win monitoring of vaccine movement: Complete information on how many doses of which batch have reached the cold chain will be updated on E-Win (Electronic Vaccine Intelligence Network). E-Win will be monitored.
This is just the beginning ...
The country is currently undergoing 6 separate vaccines, all of which will hit the market by August
Covishield: 100 million doses this month
Approval is due. 5 crore doses are ready. 100 million more doses will be ready this month.
Covexin: Possible approval in February
India has jointly developed Biotech, NIV and ICMR. The third phase trial is underway in 25 cities.
Sputnik: Approval possible by March
Russia has the vaccine. In India, Dr. Reddy's Laboratory and RDIF are jointly conducting Phase 1-2 trials. You will get a dose of Rs.700.
Zykov-D: Will come after March
Made by Zydus Cadillac. The trial of Phase 2/3 is going on together. The price is not fixed. May hit the market anytime after March.
Biological e: Possible until July
This American company is made up of Dynavex Technology and Baylor College of Houston. The second phase of the trial is underway in India. The vaccine is available until July.
HGCO-19: Possible in August
Made by Geneva Pharma, HDT Biotech, Pune. It could hit the market in August.
Also the Pfizer vaccine ... it has been approved for emergency use in Britain. Applied for approval in India. However, it was not discussed at the expert committee meeting on Friday.
Awaiting approval of indigenous vaccine
The expert committee discussed the claim of India Biotech's vaccine covexin. The committee asked the company to speed up the registration of more volunteers for the trial.
So far three companies have sought approval
So far, the Serum Institute of India (SII), Bharat Biotech and Pfizer have applied for approval for emergency use. The Serum Institute is developing a vaccine called Covishield. It was developed by Oxford University and the pharma company AstraZeneca. Bharat Biotech, which manufactures indigenous vaccines in addition to the Serum Institute, presented the panel on Wednesday. Meanwhile, US company Pfizer has asked for more time to release its data. Pfizer, however, was approved by the WHO for emergency use a day earlier.
Dry run of vaccines across the country from tomorrow
After approval from the expert panel, the companies' application will go to the Drugs Control General of India (DCGI) for final approval. The government is preparing to start vaccinations this month. For this, a dry run of vaccine has been conducted across the country tomorrow i.e. on 2nd January.
Earlier on Thursday, Drugs Control General Dr VG Somani said that the new year would be happy for us, although we would have something in this year. With this it is likely that the vaccine may be approved soon. India is the second largest country in the world affected by the US Corona. The government plans to vaccinate 300 million people in the next six to eight months.
Covishield cheapest vaccine
The Oxford vaccine is the government's biggest hope because it is cheaper. The company says it will focus on its domestic market. It will then be exported to South Asian countries and Africa.
Updates
An important meeting of the Subject Expert Committee on Corona Vaccine is underway today. Consideration will be given to giving emergency approval to the Oxford AstraZeneca Corona vaccine Covishield. According to information received, Pfizer, Bharat Biotech and Serum Institute are to give one presentation after another at this meeting. The meeting also includes Zydus Cadillac.
In a video-conference meeting with the Delhi government, the health minister said that preparations for the first phase of vaccination have been completed. A list of people who need to be vaccinated first is ready. He said the dry run of the covid vaccine would be conducted at GTB Hospital and a private hospital in Delhi.
The Serum Institute is developing a vaccine called Covishield, developed by Oxford University and Pharma AstraZeneca. Bharat Biotech, a maker of indigenous vaccine covacin in addition to the Serum Institute, made a presentation to the panel on Wednesday, while Pfizer, an American company, asked for more time to present its data.
After getting approval from the expert panel, the application of the companies will go to the Comptroller General of Drugs of India for final approval. The government is preparing to start vaccination this month, for which a dry run of the vaccine will be conducted across the country tomorrow, i.e. on January 2. The meeting is going to be held a day before the dry run.
Earlier on Thursday, Drugs Controller General Dr. VG Somani said that the new year will be happy for us, because then we will have something in hand, so it is believed that a vaccine can get approval quickly. India is the second largest corona-affected country in the world after the United States. The government plans to vaccinate 300 million people in the next six to eight months.
At the forefront of the Kovishield race
The Oxford vaccine is the government's biggest hope because it is cheaper. However, the government has not yet signed a purchase agreement with the Serum Institute. The company says it will first focus on its domestic market. It will then be exported to South Asian countries and Africa.
Adar Poonawala, CEO of the world's largest vaccine maker, said on Monday that about 50 million doses of the Oxford-AstraZeneca vaccine had already been prepared. It is planned to make 100 million doses by March next year.
Emergency use is allowed in these countries
Emergency use of the Pfizer and Modern vaccines has been approved in the United States.
Britain has approved the Pfizer and Estrogen Gene vaccines. Vaccination is going on here.
China has recently approved the vaccine of indigenous company Sinofarm with certain conditions.
Mass vaccination with the indigenous vaccine Sputnik V has also been introduced in Russia.
Canada has approved Pfizer and Bioentech vaccines.
Posts
No comments:
Post a Comment